Donor Smoking and Older Age Increases Morbidity and Mortality After Lung Transplantation
Maura Iversen
Part of the Internal Medicine Commons
Works by M. Iversen in Internal Medicine
2017
2016
AB0587 Pulmonary Arterial Hypertension as A Risk Factor for Mortality in Connective Tissue Disease with Biopsy Proven Interstitial Lung Disease
Maura Iversen
FRI0651-HPR Three Year Trends in Physical Activity in Adults with Rheumatoid Arthritis
Maura Iversen
2015
OP0103 Comparative Effectiveness of Tai Chi Versus Physical Therapy in Treating Knee Osteoarthritis: A Randomized, Single-Blind Trial
Maura Iversen
Long Term Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label, Randomized Trial
Maura Iversen
2014
2013
Lung Transplant Recipients Suspected of Antibody Mediated Rejection Treated with Plasmapheresis Have a Poor Prognosis
Maura Iversen
Time after Lung Transplantation Influence the Correlation between Acute Rejection and Frequency of Regulatory T Cells in Transbronchial Lung Biopsies
Maura Iversen
Nontuberculous Mycobacterial Disease Is Not a Contraindication to Lung Transplantation in Patients With Cystic Fibrosis: A Retrospective Analysis in a Danish Patient Population
Maura Iversen
2012
526 Chronic Allograft Dysfunction after Lung Transplantation. A Comparison of RAS vs. BOS
Maura Iversen
726 Endoscopic Treatment of Native Lung Hyperinflation with One-Way Valves in Single Lung Transplant Patients: A Multinational Experience
Maura Iversen
823 Impact of Pulmonary Venous Hypertension on Prognosis and Outcome after Lung Transplantation for End-Stage Chronic Obstructive Pulmonary Disease
Maura Iversen
2011
Erratum to: Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease
Maura Iversen
Treatment of intractable interstitial lung injury with alemtuzumab after lung transplantation
Maura Iversen
53 Everolimus Introduction and Calcineurin Reduction in Thoracic Transplant Recipients with Advanced Chronic Renal Failure
Maura Iversen
Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients. Am J Transplant 2010;10:1228–1237
Maura Iversen
Regarding: Humar et al. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
Maura Iversen
2008
530: Microarray Based Measurement of Autoantibodies Identifies Early Development of BOS in Lung Transplant Patients
Maura Iversen
85: Diffuse Alveolar Damage (DAD) after Lung Transplantation: Early Pulmonary Injury Was Not Associated with the Development of Bronchiolitis Obliterans
Maura Iversen
2007
Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease
Maura Iversen
353: Pulmonary arterial hypertension in end-stage pulmonary sarcoidosis: Assessment of the therapeutic effect of sildenafil
Maura Iversen